GB0814987D0 - Novel compound - Google Patents

Novel compound

Info

Publication number
GB0814987D0
GB0814987D0 GB0814987A GB0814987A GB0814987D0 GB 0814987 D0 GB0814987 D0 GB 0814987D0 GB 0814987 A GB0814987 A GB 0814987A GB 0814987 A GB0814987 A GB 0814987A GB 0814987 D0 GB0814987 D0 GB 0814987D0
Authority
GB
United Kingdom
Prior art keywords
novel compound
novel
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0814987A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0814987A priority Critical patent/GB0814987D0/en
Priority to US12/676,158 priority patent/US8288389B2/en
Priority to AT08803634T priority patent/ATE554081T1/en
Priority to ARP080103850A priority patent/AR068370A1/en
Priority to CL2008002622A priority patent/CL2008002622A1/en
Priority to EP08803634A priority patent/EP2195307B1/en
Priority to PCT/EP2008/061664 priority patent/WO2009030716A1/en
Priority to AU2008294708A priority patent/AU2008294708B2/en
Priority to EA201070338A priority patent/EA201070338A1/en
Priority to CA2697941A priority patent/CA2697941A1/en
Priority to CN200880115043A priority patent/CN101848903A/en
Priority to KR1020107007395A priority patent/KR20100059944A/en
Priority to MX2010002606A priority patent/MX2010002606A/en
Priority to JP2010523502A priority patent/JP5379796B2/en
Priority to TW097133837A priority patent/TW200918527A/en
Priority to ES08803634T priority patent/ES2384414T3/en
Priority to PE2008001550A priority patent/PE20091199A1/en
Priority to BRPI0816304 priority patent/BRPI0816304A2/en
Priority to US12/203,946 priority patent/US20090170869A1/en
Publication of GB0814987D0 publication Critical patent/GB0814987D0/en
Ceased legal-status Critical Current

Links

GB0814987A 2007-09-06 2008-08-15 Novel compound Ceased GB0814987D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB0814987A GB0814987D0 (en) 2008-08-15 2008-08-15 Novel compound
US12/676,158 US8288389B2 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine H3 receptor
AT08803634T ATE554081T1 (en) 2007-09-06 2008-09-04 PIPERAZINE DERIVATIVES WITH AFFINITY FOR HISTAMINE H3 RECEPTOR
ARP080103850A AR068370A1 (en) 2007-09-06 2008-09-04 1- (1-METHYTILE) -4 - {[4- (TETRAHIDRO-2H-PIRAN-4-ILOXI) PHENYL] CARBONIL} PIPERAZINE AND ITS HYDROCLORIDE SALT, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ITS USE IN THE TREATMENT OR PROPHYLAXIS OF NEUROLOGICAL DISEASES AND PROCESS FOR PREPARATION.
CL2008002622A CL2008002622A1 (en) 2007-09-06 2008-09-04 1- (1-methylethyl) -4 - {[4- (tetrahydro-2h-pyran-4-yloxy) phenyl] carbonyl} piperazine and its hydrochloride salt; crystalline forms of salt; Preparation process; pharmaceutical composition; and use for the treatment or prophylaxis of cognitive impairment, fatigue or sleep disorder.
EP08803634A EP2195307B1 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor
PCT/EP2008/061664 WO2009030716A1 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor
AU2008294708A AU2008294708B2 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine H3 receptor
EA201070338A EA201070338A1 (en) 2007-09-06 2008-09-04 DERIVATIVES OF PIPERAZINE, possessing affinity with respect to histamine H3 receptor
CA2697941A CA2697941A1 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor
CN200880115043A CN101848903A (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine H3 receptor
KR1020107007395A KR20100059944A (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor
MX2010002606A MX2010002606A (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor.
JP2010523502A JP5379796B2 (en) 2007-09-06 2008-09-04 Piperazine derivatives having affinity for histamine H3 receptor
TW097133837A TW200918527A (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine H3 receptor
ES08803634T ES2384414T3 (en) 2007-09-06 2008-09-04 Piperazine derivative that has an affinity for the histamine H3 receptor
PE2008001550A PE20091199A1 (en) 2007-09-06 2008-09-04 PIPERAZINE DERIVATIVE HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR
BRPI0816304 BRPI0816304A2 (en) 2007-09-06 2008-09-04 PIPERAZINE DERIVATIVE WITH AFFINITY FOR HISTAMINE H3 RECEIVER
US12/203,946 US20090170869A1 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0814987A GB0814987D0 (en) 2008-08-15 2008-08-15 Novel compound

Publications (1)

Publication Number Publication Date
GB0814987D0 true GB0814987D0 (en) 2008-09-24

Family

ID=39812135

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0814987A Ceased GB0814987D0 (en) 2007-09-06 2008-08-15 Novel compound

Country Status (1)

Country Link
GB (1) GB0814987D0 (en)

Similar Documents

Publication Publication Date Title
GB0818033D0 (en) Novel compound
GB0806536D0 (en) Novel compounds
GB0804989D0 (en) Compound
EP2284159A4 (en) 5-hydroxypyrimidine-4-carboxamide compound
GB0803494D0 (en) Compound
GB0804592D0 (en) Novel compounds
IL207035A0 (en) Benzylpiperizine compound
EP2370440A4 (en) Novel compounds
GB0804326D0 (en) Novel compounds
GB0800411D0 (en) Novel compounds
GB0823316D0 (en) Compound
GB0812700D0 (en) Novel compound
GB0814987D0 (en) Novel compound
GB0811384D0 (en) Novel compound
GB0809102D0 (en) Novel compound
GB0807021D0 (en) Novel compound
GB0806005D0 (en) Compound
GB0815806D0 (en) Compound
GB0820249D0 (en) Compound
GB0820915D0 (en) Compound
GB0820916D0 (en) Compound
GB0820918D0 (en) Compound
GB0820919D0 (en) Compound
GB0822635D0 (en) Compound
GB0812580D0 (en) Compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)